HHG Health

In response to the novel coronavirus (SARS-CoV-2) outbreak, Thermo Fisher Scientific has worked rapidly to develop a new multiplex real-time RT-PCR diagnostic kit to enable clinical and public health laboratories to quickly diagnose COVID-19 caused by SARS-CoV-2 infection. The Applied Biosystems TaqPath COVID-19 kit is a fast, highly sensitive multiplex diagnostic solution that contains both the assays and controls needed for the real-time PCR detection of RNA from the SARS-CoV-2 virus.

​

Approved sample types include:

• Bronchoalveolar lavage (BAL)

• Mid-turbinate swabs

• Nasal swabs

• Nasopharyngeal swabs

• Nasopharyngeal aspirate (nasal aspirate)

• Oropharyngeal swabs

​

For Emergency Use Authorization (EUA) only. For prescription use only. For in vitro diagnostic use.